1Trauma Nursing Research Center, Kashan University of Medical Sciences, Kashan, IR Iran
2Nursing and Midwifery Care Research Center, School of Nursing and Midwifery, Isfahan University of Medical Sciences, Isfahan, IR Iran
3Department of Nutrition, Kashan University of Medical Sciences, Kashan, IR Iran
4Department of Society Medicine, Kashan University of Medical Sciences, Kashan, IR Iran
5Research Center of Barij Essence, Kashan, IR Iran
Background Premenstrual Syndrome (PMS) is a common problem in women. Zataria multiflora Boiss is a valuable plant. This herbal plant has been used in different conditions. Objectives The study was performed to investigate the effects of Zataria multiflora Boiss to control PMS symptoms. Materials and Methods This study was a double-blinded, prospective randomized trial. The study population was the college students living in the dormitories of Isfahan University. Eighty-eight eligible students were randomly divided to intervention and control groups. Students completed the prospective record of the impact and severity of menstrual symptoms (PRISM) calendar including 30 PMS symptoms for four menstrual cycles (two cycles before, and two after the intervention). The intervention group received pearls containing 20 mg of Zataria multi-flora essence (four pearls each day) for two menstrual cycles, seven days before menstruation. The mean difference of PMS severity score between groups was analyzed with Mann-Whitney U test. The difference in frequency score of symptoms was analyzed using repeated-measure analysis of variance. Results Thirty-eight students in intervention and 37 students in placebo group completed the study. The groups had no significant difference regarding the severity of PMS. Both groups showed a significant improvement in PMS severity score after the intervention. The repeated-measure analysis of variance showed that the frequency of symptoms decreased significantly in the cycles, but it was not different in intervention and placebo groups. Conclusions Our findings did not support the use of Zataria multiflora Boiss in premenstrual syndrome.